| Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features M Zuberi, R Mir, J Das, I Ahmad, J Javid, P Yadav, M Masroor, S Ahmad, ... Clinical and Translational Oncology 17, 779-787, 2015 | 150 | 2015 |
| Utility of serum miR-125b as a diagnostic and prognostic indicator and its alliance with a panel of tumor suppressor genes in epithelial ovarian cancer M Zuberi, I Khan, R Mir, G Gandhi, PC Ray, A Saxena PloS one 11 (4), e0153902, 2016 | 76 | 2016 |
| Simple multiplex RT-PCR for identifying common fusion BCR-ABL transcript types and evaluation of molecular response of the a2b2 and a2b3 transcripts to Imatinib resistance in … R Mir, I Ahmad, J Javid, M Zuberi, P Yadav, R Shazia, M Masroor, S Guru, ... Indian journal of cancer 52 (3), 314-318, 2015 | 33 | 2015 |
| Inhibition of RAS: proven and potential vulnerabilities M Zuberi, I Khan, JP O'Bryan Biochemical Society Transactions 48 (5), 1831-1841, 2020 | 25 | 2020 |
| The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer M Zuberi, I Khan, G Gandhi, PC Ray, A Saxena Tumor Biology 37, 11259-11266, 2016 | 25 | 2016 |
| The promising signatures of circulating microRNA-145 in epithelial ovarian cancer patients M Zuberi, R Mir, I Khan, J Javid, SA Guru, M Bhat, MP Sumi, I Ahmad, ... MicroRNA 9 (1), 49-57, 2020 | 23 | 2020 |
| Association of GABAA receptor gene with epilepsy syndromes MA Bhat, SA Guru, R Mir, AA Waza, M Zuberi, MP Sumi, S Bodeliwala, ... Journal of Molecular Neuroscience 65, 141-153, 2018 | 18 | 2018 |
| RASSF1 and PTEN promoter hypermethylation influences the outcome in epithelial ovarian cancer M Zuberi, R Mir, S Dholariya, I Najar, P Yadav, J Javid, S Guru, M Mirza, ... Clinical Ovarian and Other Gynecologic Cancer 7 (1-2), 33-39, 2014 | 18 | 2014 |
| Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients P Yadav, M Masroor, K Tanwer, R Mir, J Javid, I Ahmad, M Zuberi, ... Clinical and Translational Oncology 18, 728-734, 2016 | 16 | 2016 |
| CC genotype of anti-apoptotic gene BCL-2 (− 938 C/A) is an independent prognostic marker of unfavorable clinical outcome in patients with non-small-cell lung cancer J Javid, R Mir, M Mirza, A Imtiyaz, Y Prasant, Z Mariyam, PK Julka, ... Clinical and Translational Oncology 17, 289-295, 2015 | 16 | 2015 |
| Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants I Khan, A Koide, M Zuberi, G Ketavarapu, E Denbaum, KW Teng, JM Rhett, ... Cell reports 38 (6), 2022 | 14 | 2022 |
| Ectopic PD-L1 expression in JAK2 (V617F) myeloproliferative neoplasm patients is mediated via increased activation of STAT3 and STAT5 SA Guru, MP Sumi, R Mir, AA Waza, MA Bhat, M Zuberi, P Lali, A Saxena Human cell 33, 1099-1111, 2020 | 14 | 2020 |
| Clinical implication of EGF A61G polymorphism in the risk of non small cell lung adenocarcinoma patients: a case control study M Masroor, J Amit, J Javid, R Mir, Y Prasant, A Imtiyaz, Z Mariyam, ... Asian Pacific Journal of Cancer Prevention 16 (17), 7529-7534, 2015 | 12 | 2015 |
| Inhibition of RAS-driven signaling and tumorigenesis with a pan-RAS monobody targeting the Switch I/II pocket L Wallon, I Khan, KW Teng, A Koide, M Zuberi, J Li, G Ketavarapu, ... Proceedings of the National Academy of Sciences 119 (43), e2204481119, 2022 | 11 | 2022 |
| Targeting the KRAS α4-α5 allosteric interface inhibits pancreatic cancer tumorigenesis I Khan, C Marelia-Bennet, J Lefler, M Zuberi, E Denbaum, A Koide, ... Small GTPases 13 (1), 114-127, 2022 | 10 | 2022 |
| Role of SCN1A and SCN2A Gene Polymorphisms in Epilepsy Syndromes-A Study from India VP Alpana Saxena, Musadiq Ahmad Bhat, Sameer Ahmad Guru, Rashid Mir, Ajaz ... Journal of Neurology and Neuroscience 9, 2018 | 10 | 2018 |
| Potential impact of (rs 4645878) BAX promoter− 248G> A and (rs 1042522) TP53 72Arg> pro polymorphisms on epithelial ovarian cancer patients S Dholariya, R Mir, M Zuberi, P Yadav, G Gandhi, N Khurana, A Saxena, ... Clinical and Translational Oncology 18, 73-81, 2016 | 10 | 2016 |
| Inactivation of P16 (INK4a) gene by promoter hypermethylation is associated with disease progression in chronic myelogenous leukaemia A Imtiyaz, M Rashid, G Sameer, J Jamsheed, Z Mariyam J Carcinogene Mutagene 4, 141, 2013 | 10 | 2013 |
| Broadband modelling of Orphan gamma ray flares SR Patel, D Bose, N Gupta, M Zuberi Journal of High Energy Astrophysics 29, 31-39, 2021 | 9 | 2021 |
| Epigenetic silencing of DAPK1 gene is associated with faster disease progression in India populations with chronic myeloid leukemia R Mir, I Ahmad, J Javid, S Farooq, P Yadav J Cancer Sci Ther 5, 144-149, 2013 | 9 | 2013 |
